Grifols (MEX:GRFP N) Short Interest


MEX:GRFP N Grifols SA MEX:GRFP N
83 GF Score
Price MXN126.63
GF Value MXN154.24
! 6 Warning Signs
View Full Analysis

What is Grifols Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

MEX:GRFP N vs LLY, JNJ, ABBV: Short Interest Comparison

For the Drug Manufacturers - General subindustry, Grifols's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grifols Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grifols's Short Interest distribution charts can be found below:

* The bar in red indicates where Grifols's Short Interest falls into.


MEX:GRFP N
83GF Score
Grifols SA MEX:GRFP N
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Grifols (MEX:GRFP N) Overvalued in 2026?

Based on GuruFocus' analysis, Grifols stock appears to be undervalued. The current stock price of MXN126.63 is trading 17.9% below its estimated GF Value™ of MXN154.24.

Key valuation signals for MEX:GRFP N:

  • Short Interest:
  • GF Value™: MXN154.24 vs. price of MXN126.63 (17.9% below fair value)
  • GF Score™: 83/100 with 6 warning signs

No single metric tells the full story. See the MEX:GRFP N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Grifols Business Description

Address Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
83GF Score

Get the complete analysis for MEX:GRFP N

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN126.63
Price
MXN154.24
GF Value